Nothing Special   »   [go: up one dir, main page]

GR1008786B - Haemodialysis with ferric pyrophosphate - Google Patents

Haemodialysis with ferric pyrophosphate

Info

Publication number
GR1008786B
GR1008786B GR20140100658A GR20140100658A GR1008786B GR 1008786 B GR1008786 B GR 1008786B GR 20140100658 A GR20140100658 A GR 20140100658A GR 20140100658 A GR20140100658 A GR 20140100658A GR 1008786 B GR1008786 B GR 1008786B
Authority
GR
Greece
Prior art keywords
haemodialysis
iron
ferric pyrophosphate
pyrophosphate
ferric
Prior art date
Application number
GR20140100658A
Other languages
Greek (el)
Inventor
Πολυξενη Στυλιανου Γαμβρουλη
Original Assignee
Βερμα Ντραγκς - Verma Drugs Abee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Βερμα Ντραγκς - Verma Drugs Abee filed Critical Βερμα Ντραγκς - Verma Drugs Abee
Priority to GR20140100658A priority Critical patent/GR1008786B/en
Publication of GR1008786B publication Critical patent/GR1008786B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Emergency Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The enriching of the haemodialysis solution with ferric 5 pyrophosphate (12 mg/dl or 120mg/lt) has been proven to be safe and the iron quantity sufficient in order to maintain the iron balance in the majority of patients subjected to haemodialysis. Furthermore, non-bound iron is hardly liberated due to the ferric pyrophosphate chemical features.
GR20140100658A 2014-12-24 2014-12-24 Haemodialysis with ferric pyrophosphate GR1008786B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GR20140100658A GR1008786B (en) 2014-12-24 2014-12-24 Haemodialysis with ferric pyrophosphate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20140100658A GR1008786B (en) 2014-12-24 2014-12-24 Haemodialysis with ferric pyrophosphate

Publications (1)

Publication Number Publication Date
GR1008786B true GR1008786B (en) 2016-06-10

Family

ID=56990157

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20140100658A GR1008786B (en) 2014-12-24 2014-12-24 Haemodialysis with ferric pyrophosphate

Country Status (1)

Country Link
GR (1) GR1008786B (en)

Similar Documents

Publication Publication Date Title
MX2021010528A (en) Methods and compositions for treating ulcers.
MX2021014709A (en) Methods for increasing red blood cell levels and treating sickle-cell disease.
MY198202A (en) Container containing a nicotine solution
MX2022013713A (en) Combination therapy with an anti - hyaluronan agent and a tumor - targeted taxane.
MD20170020A2 (en) Compositions and methods of use for treating metabolic disorders
MY185016A (en) Progenitor cells of mesodermal lineage
SG10201806787VA (en) Modulators of complement factor b
PH12014502336A1 (en) Iron supplementation of rice kernels
PH12017500052A1 (en) Myo-inositol and probiotics and uses
MX2017006015A (en) Apilimod for use in the treatment of renal cancer.
MX2018002546A (en) Compositions comprising an urolithin compound.
NZ708537A (en) Method for the preparation of human albumin with reduced level of dissolved oxygen
PH12017502403A1 (en) Musk composition and methods of use thereof
EA201591424A1 (en) METHODS OF TREATMENT OF IRON DEFICIENCY WITH SOLUBLE IRON PYROPHOSPHATE
SG10201811078XA (en) Method Of Treatment Of Hypoxia Inducible Factor (HIF)-Related Conditions
NZ713129A (en) Oxprenolol compositions for treating cancer
PH12019550209A1 (en) A nutritional composition for use to enhance attention and/or reduce impulsivity
MX2014012535A (en) Combination therapy of anti-mif antibodies and chemotherapeutics.
GR1008786B (en) Haemodialysis with ferric pyrophosphate
MX2018011512A (en) Use of insulin for promoting gastric emptying.
AU366515S (en) Vessel for electrochemical treatment
AU201612048S (en) Heart shaped pouch with fur
MX2016006882A (en) Infant nutrition for improvement in insulin sensitivity later in life.
EA201591856A1 (en) TREATMENT OF HEART FAILURE
MD4410B1 (en) Balanced infusion solution

Legal Events

Date Code Title Description
PG Patent granted

Effective date: 20160729